Pharma Business - March 4, 2026
Thermo Fisher Scientific opens distribution and labeling center in Uppsala
The company is opening of a new 8,000-square-meter center supporting its immunodiagnostics business in Uppsala.
Upcoming events - March 4, 2026
On the agenda: The future of Nordic healthcare
Vitalis, a four-day event held at Svensk Mässan in Gothenburg on May 4-7, will deliver insight, strategy, and connections – both within and beyond the sessions – that drive the future of healthcare.
Financing - March 3, 2026
SynAct Pharma has carried out a directed issue of new shares
Through the directed issue, the company will receive approximately SEK 51.9 million.
In a new job - March 3, 2026
SynAct Pharma appoints new Chief Financial Officer
Ann Kristin Led is a seasoned financial executive with extensive experience across the life sciences, pharmaceutical, and medtech sectors.
Biotech article - March 3, 2026
Elicera provides update on preclinical CAR T-cell program for glioblastoma
Elicera Therapeutics provides an update on the development of its iTANK-armed CAR T-cell therapy candidate ELC-401 for the treatment of recurrent glioblastoma.
In a new job - March 3, 2026
The CEO of Bavarian Nordic steps down
The Board of Directors has entered into an agreement with CEO, Paul Chaplin, who wishes to step down for personal reasons.
